A Driving Simulation study of tolperisone

Trial Profile

A Driving Simulation study of tolperisone

Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Jul 2017

At a glance

  • Drugs Tolperisone (Primary) ; Cyclobenzaprine
  • Indications Muscle spasticity; Spasm
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jul 2017 According to a Neurana Pharmaceuticals media release, the company anticipates to have topline results from the study in late third quarter 2017.
    • 26 Jul 2017 Status changed from planning to recruiting, according to a Neurana Pharmaceuticals media release.
    • 01 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top